Skip to content

Short-term and long-term efficacy of acupuncture in the treatment of chronic urticaria: a randomized, double-dummy, parallel controlled study

Short-term and long-term efficacy of acupuncture in the treatment of chronic urticaria: a randomized, double-dummy, parallel controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071993
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic urticaria

Interventions

Experimental group :acupuncture + placebo drugs
control group:Ebastine + sham acupuncture

Sponsors

Chengdu University of Traditional Chinese Medicine/ Affiliated hospital of Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who met the diagnostic criteria of chronic spontaneous urticaria in the EAACI/GA2LEN/EDF/WAO guidelines for the diagnosis and treatment of urticaria (2017 edition) and the Chinese Urticaria Guidelines (2014 edition); (2) those aged 18 to 70 years old; (3) no use of antihistamines within 2 weeks before study entry, no use of steroids or immunosuppressive drugs within 1 month; (4) clinical investigators with UAS7=16 before entering the study; (5) not participating in other ongoing clinical investigators; (6) signed informed consent and volunteered to participate in the study.

Exclusion criteria

Exclusion criteria: (1) patients with unconsciousness, inability to express subjective discomfort symptoms and mental patients; (2) advanced malignant tumor or other serious wasting disease, easily complicated with infection and bleeding; (3) complicated with cardiovascular, hepatic, renal, digestive, hematopoietic system and other serious primary diseases; (4) pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Improvement in UAS7 at week 20 compared with UAS7 at baseline;

Secondary

MeasureTime frame
Improvement in UAS7 at week 4 compared with UAS7 at baseline;Dermatology Life Quality Index;Visual Analogue Scale of itching;Self-Rating Anxiety Scale;Self-Rating Depression Scale;

Countries

China

Contacts

Public ContactXianjun Xiao

Chengdu University of Traditional Chinese Medicine

xiaoxianjun@cdutcm.edu.cn+86 158 2855 4729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026